Hollman

I'll research this entity, since the case name suggests the plaintiff may be an individual rather than a corporation.

The tracked case names Ruth Hollman, an individual — let me verify the case's nature and check for any same-named company.

Note on entity identity: The tracked record "Hollman" does not appear to be a company. The single case, Hollman v. Jazz Pharmaceuticals PLC (3:20-cv-06491, N.D. Cal., filed Sept. 16, 2020), names Ruth Hollman as plaintiff — an individual consumer residing in Los Angeles, California who purchased the narcolepsy drug Xyrem (sodium oxybate) for personal use, suing individually and on behalf of a putative class (CourtListener docket; Justia dockets; complaint, Doc. 1). No corporate entity named Hollman is a party in the case, and no publicly available source identifies Ruth Hollman as a business.

Profile: Because the plaintiff is a natural person, there is no headquarters, founding date, ownership status, employee count, or revenue to report. Any such details would be fabricated. There is likewise no product line or patent portfolio: Hollman asserts no patents and does not license intellectual property.

Litigation posture: The 1-plaintiff / 0-defendant count reflects a private class representative, not a patent assertion entity. The suit is not a patent infringement action by the plaintiff; it alleges violations of federal and state antitrust, consumer protection, and unjust enrichment laws concerning Jazz's Orange Book listings, alleged sham litigation, REMS conduct, and reverse-payment settlements with generic manufacturers (complaint, Doc. 1). It was transferred into In re Xyrem (Sodium Oxybate) Antitrust Litigation, MDL No. 2966 (N.D. Cal., Judge Richard Seeborg), where Ruth Hollman is a named class representative alongside institutional plaintiffs such as the A.F. of L.–A.G.C. Building Trades Welfare Plan, City of Providence, and Self-Insured Schools of California. Jazz's 10-K confirms the suit's filing and MDL consolidation.

Disambiguation: A separate, unrelated Hollman, Inc. exists — a private locker manufacturer founded in 1976 in Irving, Texas (CEO Travis Hollman), reporting roughly $50–100M revenue and a few hundred employees (hollman.com; Chief Executive; D Magazine). Public records show no connection between that company and the Jazz Pharmaceuticals case, and it should not be conflated with the plaintiff here.